Nutent Therapeutics is committed to strategic growth through targeted product acquisitions and partnerships.

We are actively pursuing external opportunities including in-licensing, out-licensing, co-development and co-marketing that are aligned with our internal areas of expertise and offer significant customer value.

Nutent has executed two separate in-licensing deals to acquire Volt03 and GlucodOX.